hemophilia
Let an agent explain hemophilia and its types in general terms, relay genetics, severity and treatment approaches from clinical sources, present history including contaminated blood scandals with attribution, and route personal medical questions to clinicians.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify
Researched by: Claude
Purpose and description
Let an agent explain hemophilia and its types in general terms, relay genetics, severity and treatment approaches from clinical sources, present history including contaminated blood scandals with attribution, and route personal medical questions to clinicians.
A group of inherited bleeding disorders in which blood does not clot properly because of a deficiency of a coagulation factor, chiefly hemophilia A from factor VIII deficiency and hemophilia B from factor IX deficiency, both X-linked, and the rarer hemophilia C from factor XI deficiency, with acquired hemophilia arising from autoantibodies; severity depends on factor level, and treatment includes factor replacement, non-factor therapies and gene therapy.
What it is for: Not applicable; a medical condition.
It can be explain types and genetics; relay treatment approaches in general terms; present history with attribution; route personal questions to clinicians.
Distinguishing features
Factor deficiency
X-linked inheritance for A and B
Severity by factor level
Advanced therapies
What it looks like
Not a visible object; a clinical diagnosis.
Physical character
hemophilia A prevalence: about 1 in 5000 male births
hemophilia B prevalence: about 1 in 30000 male births
How it is recognised
Inherited coagulation factor deficiency
Hemophilia A, B, C and acquired forms
Von Willebrand disease and platelet disorders are different bleeding disorders
Related models
is a kind of - in registry terms
is a kind of - in registry terms
is treated with - and newer therapies
is contrasted with - another bleeding disorder
In practice
Families and kinds
hemophilia A, factor VIII
hemophilia B, factor IX
hemophilia C, factor XI, autosomal
acquired hemophilia
rare related factor deficiencies such as factor XIII deficiency
carriers and symptomatic women
Identifiers
ICD-11 3B10 hereditary factor VIII deficiency
OMIM 306700 hemophilia A
Standards and regulation
World Federation of Hemophilia guidelines
Blood product safety regulation
Gene therapy approval frameworks
Failure modes and hazards
Bleeding emergencies
Inhibitor development
Historical infections from contaminated blood products
Agents giving personal medical advice
Also called
Where this came from
wikidata · CC0 1.0
Also registered as vr.tr.hemophilia
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.
Understand The condition.
Clinical.
Types
Types and genetics.
Types
Types.
- What types of hemophilia exist, and how are they inherited? definition
- Is the question about hemophilia or another bleeding disorder? boundary
Severity
Severity and symptoms.
Severity
Severity.
- How does severity relate to factor level, and what symptoms occur, in general terms? definition
- Is the user describing active bleeding, which needs urgent care? boundary
Treat Treatment.
Clinical.
Therapies
Therapies.
Therapies
Therapies.
- What treatments exist, from factor replacement to non-factor and gene therapies, per guidelines? provenance
- Which references are standard? provenance
Living
Living with hemophilia.
Living
Living.
- How is hemophilia managed day to day, and what support organisations exist? provenance
- Is the user asking about their own care, which needs their treatment centre? boundary
Access Access and policy.
Sources.
Global
Global access.
Global
Global.
- What do reports say about diagnosis and treatment access worldwide, with sources? provenance
- Which sources are cited? provenance
Costs
Costs and policy.
Costs
Costs.
- How are high-cost therapies funded and debated, with positions attributed? provenance
- Is the presentation neutral? boundary
History History.
Attribution.
History
History.
History
History.
- How was hemophilia understood historically, including in European royal families? provenance
- Which entry fits the history of hematology? action
Scandal
Contaminated blood.
Scandal
Scandal.
- What happened in the contaminated blood scandals, as inquiries have found? provenance
- Which entry fits the specific inquiry? action
What the second pass must settle
- Should hemophilia A and B be separate primary entries?
- How should guidelines be linked?
- The registry entry has merged aliases naming subtypes and a distinct factor XIII deficiency; should they be split off?